Original article

Relapsing polychondritis mainly with airway involvement: analysis of clinical characteristics

  • HU Jiaqi ,
  • JIN Zhengyi ,
  • LIU Qilong ,
  • JI Lianmei ,
  • MA Taiyan ,
  • GAO Jie
Expand
  • Department of Rheumatology and Immunology, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China

Received date: 2024-11-04

  Online published: 2025-03-11

Abstract

Objective To investigate the clinical characteristics of patients with relapsing polychondritis (RP) involving airway. Methods The clinical data of 141 RP patients hospitalized in the First Affiliated Hospital of Naval Medical University from July 2007 to December 2023 were analyzed retrospectively. Results The incidence of airway involvement in RP patients was 58.87%, among which airway wall thickening was the most common. RP patients with airway involvement were diagnosed at a later age (P=0.011). RP patients without airway involvement were more likely to have ear cartilage, eye and cardiovascular system involvement (P=0.008, P=0.009 and P=0.021); the hypersensitive C-reactive protein and platelet counts in RP patients without airway involvement were higher than those in RP patients with airway involvement (P=0.023, P=0.013), while the neutrophil counts in the patients were lower than those in RP patients with airway involvement (P=0.018). Univariate Logistic regression analysis showed that age at diagnosis and neutrophil count were positively correlated with airway involvement. In contrast, ear cartilage, eye and cardiovascular involvement, erythrocyte sedimentation rate, hypersensitive C-reactive protein, platelet count, and alanine transferase were negatively correlated with airway involvement. Multivariate Logistic regression analysis confirmed that age at diagnosis and neutrophil count were independent risk factors for airway involvement. Conclusions Airway involvement in RP patients is related to age at diagnosis and neutrophil count. The patients should receive regular chest CT and bronchial examination if necessary.

Cite this article

HU Jiaqi , JIN Zhengyi , LIU Qilong , JI Lianmei , MA Taiyan , GAO Jie . Relapsing polychondritis mainly with airway involvement: analysis of clinical characteristics[J]. Journal of Internal Medicine Concepts & Practice, 2024 , 19(06) : 379 -384 . DOI: 10.16138/j.1673-6087.2024.06.05

References

[1] Padoan R, Campaniello D, Iorio L, et al. Biologic therapy in relapsing polychondritis: navigating between options[J]. Expert Opin Biol Ther, 2022, 22(5):661-671.
[2] Cardoneanu A, Rezus II, Burlui AM, et al. Autoimmunity and autoinflammation: relapsing polychondritis and VEXAS syndrome challenge[J]. Int J Mol Sci, 2024, 25(4):2261.
[3] 徐健, 王丹丹, 石桂秀, 等. 复发性多软骨炎诊疗规范[J]. 中华内科杂志, 2022, 61(05):525-530.
[4] Dion J, Costedoat-Chalumeau N, Sène D, et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients[J]. Arthritis Rheumatol, 2016, 68(12):2992-3001.
[5] Zhai SY, Guo RY, Zhang C, et al. Clinical analysis of relapsing polychondritis with airway involvement[J]. J Laryngol Otol, 2023, 137(1):96-100.
[6] Jafarpour M, Saberivand M, Saemi M, et al. A multicenter study of long-term outcomes of relapsing polychondritis in Iran[J]. Sci Rep, 2024, 14(1):16486.
[7] Damiani JM, Levine HL. Relapsing polychondritis—report of ten cases[J]. Laryngoscope, 1979, 89(6 Pt 1):929-946.
[8] McAdam LP, O’Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature[J]. Medicine (Baltimore), 1976, 55(3):193-215.
[9] Mertz P, Costedoat-Chalumeau N, Ferrada MA, et al. Relapsing polychondritis: clinical updates and new differential diagnoses[J]. Nat Rev Rheumatol, 2024, 20(6):347-360.
[10] Liu Y, Cheng L, Zhao M, et al. Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters[J]. Front Immunol, 2023, 14:1274677.
[11] Kuo IC, Hsieh CI, Lee YC, et al. Diagnostic challenges and management of relapsing polychondritis with large-airway involvement: a case series and literature review[J]. Life (Basel), 2024, 14(9):1194.
[12] 张海艇, 王立, 闫琳毅, 等. 复发性多软骨炎患者临床特征分析[J]. 中华医学杂志, 2015 (29): 2375-2378.
[13] Lin DF, Yang WQ, Zhang PP, et al. Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature[J]. Rheumatology international, 2016, 36: 1003-1009.
[14] Rafeq S, Trentham D, Ernst A. Pulmonary manifestations of relapsing polychondritis[J]. Clin Chest Med, 2010, 31(3):513-518.
[15] de Montmollin N, Dusser D, Lorut C, et al. Tracheobronchial involvement of relapsing polychondritis[J]. Autoimmun Rev, 2019, 18(9):102353.
[16] Shimizu J, Yamano Y, Kawahata K, et al. Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics[J]. Medicine (Baltimore), 2018, 97(42):e12837.
[17] Yin R, Xu D, Wang Q, et al. Predictors and prognosis of tracheostomy in relapsing polychondritis[J]. Rheumatology (Oxford), 2024, 63(11):3042-3049.
[18] Jalaber C, Puéchal X, Saab I, et al. Differentiating tracheobronchial involvement in granulomatosis with polyangiitis and relapsing polychondritis on chest CT: a cohort study[J]. Arthritis Res Ther, 2022, 24(1):241.
[19] Civan C, I??k EG, Has ?im?ek D, et al. Diagnosis and evaluation of treatment response in relapsing polychondritis using 18F-FDG PET/CT[J]. Mol Imaging Radionucl Ther, 2024, 33(2):109-111.
[20] Zhang L, Yun S, Wu T, et al. Clinical patterns and the evolution of relapsing polychondritis based on organ involvement: a Chinese retrospective cohort study[J]. Orphanet J Rare Dis, 2021, 16(1):225.
[21] 蒋黎, 曹晓宇, 赵梦珠, 等. 呼吸道受累复发性多软骨炎患者的临床特点[J]. 中华临床免疫和变态反应杂志, 2021, 15(3):312-317.
[22] 刘禹. 哮喘气道中性粒细胞炎症表型的动态观察和临床意义研究[D]. 重庆: 第三军医大学, 2015.
Outlines

/